Catalog Number S-50-040-120-P6 |
Device Problems
Detachment Of Device Component (1104); Difficult or Delayed Positioning (1157); Improper or Incorrect Procedure or Method (2017)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 01/31/2017 |
Event Type
malfunction
|
Manufacturer Narrative
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all additional relevant information.The 5.0x60 supera referenced in b5 is filed under a separate medwatch report number.
|
|
Event Description
|
It was reported that the 5.0x60 supera stent delivery system (sds) was advanced to the target lesion in the superficial femoral artery (sfa) to the proximal popliteal artery.The stent was mostly deployed when there was concern about the guide wire placement.During image review, the sds and partially deployed stent were inadvertently pulled back to the mid sfa where the rest of the stent was deployed in the non-target area.The 5.0x40 supera sds was inserted and advanced to the target lesion, one cm of stent was deployed when it was decided to change out the guide wire.The sds was removed and it was noted that the tip of the sds had separated and remained in the sheath.The guide wire and sheath were removed together, successfully removing the separated tip.A new guide wire was inserted and a new supera sds was successfully deployed to complete the procedure.There was no adverse patient sequela or a clinically significant delay in the procedure.No additional information was provided.
|
|
Manufacturer Narrative
|
(b)(4).Evaluation summary: visual inspection was performed on the returned device.The tip separation was confirmed.The deployment issue was not confirmed as it was due to use error.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other incidents.The supera instruction for use (ifu) instructs: prior to removal of the delivery system, ensure the supera stent (8) is completely deployed, the thumb slide is retracted, the system lock and deployment lock are locked (in the path of the thumb slide).Based on the reported information, the difficulties were related to use error and there is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
|
|
Search Alerts/Recalls
|